期刊文献+

靶向治疗在胆道恶性肿瘤中的临床应用现状及进展

The current status and progress of clinical application of targeted therapy in biliary tract malignant tumors
下载PDF
导出
摘要 胆道恶性肿瘤严重威胁人类身体健康,手术、化疗和放疗等治疗手段临床获益有限,靶向治疗作为一种基于肿瘤特异性基因变异或蛋白质表达而开发的个体化治疗方法,药物通过特定靶标作用于肿瘤细胞产生抗肿瘤作用。本文将对胆道恶性肿瘤靶向治疗研究及进展进行简要介绍并探索未来发展方向。 Biliary tract malignant tumor is a serious threat to human health.The clinical benefits of surgery,chemotherapy and radiotherapy are limited.Targeted therapy is an individualized treatment method based on tumor-specific gene mutation or protein expression.Drugs act on tumor cells through specific targets to produce anti-tumor effects.This article will briefly introduce the research and progress of targeted therapy for biliary malignant tumors and explore the future development direction.
作者 刘千琳 张鹏飞 LIU Qianlin;ZHANG Pengfei(Cancer Center,West China Hospital,Sichuan University,Sichuan Chengdu 610041,China)
出处 《现代肿瘤医学》 CAS 北大核心 2023年第23期4472-4476,共5页 Journal of Modern Oncology
关键词 胆道恶性肿瘤 治疗 靶向药物 biliary malignant tumor treatment targeted drugs
  • 相关文献

参考文献12

二级参考文献71

  • 1Jianzhen Lin,Xu Yang,Junyu Long,Songhui Zhao,Jinzhu Mao,Dongxu Wang,Yi Bai,Jin Bian,Lei Zhang,Xiaobo Yang,Anqiang Wang,Fucun Xie,Weiwei Shi,Huayu Yang,Jie Pan,Ke Hu,Mei Guan,Lin Zhao,Li Huo,Yilei Mao,Xinting Sang,Kai Wang,Haitao Zhao.Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma[J].Hepatobiliary Surgery and Nutrition,2020,9(4):414-424. 被引量:25
  • 2Yoon S, Seger R. The extracellular signal-regulated kinase : muhiple substrates regulate diverse cellular functions [ J]. Growth Factors, 2006,24(1) :21-44.
  • 3Scheid MP, Schubert KM, Duronio V. Regulation of bad phosphoryla- tion and association with Bcl-x (L) by the MAPK/Erk kinase [ J ]. J Biol Chem, 1999,274 (43) : 31108 -31113.
  • 4Diaz-Flores E, Shannon K. Targeting oncogenic Ras [ J]. Genes Dev, 2007,21 (16) :1959-1992.
  • 5Bos JL. Ras oncogenes in human cancer: a review[ J]. Cancer Res, 1989,49 ( 17 ) :4682-4689.
  • 6Drosten M, Dhawahir A, Sum EY, et al. Genetic analysis of Ras sig- nalling pathways in cell proliferation, migration and survival[J]. EM- BO J,2010,29(6) 29 : 1091-1104.
  • 7Solit DB, Garraway LA, Pratilas CA, et al. BRAF mutation predicts sensitivity to MEK inhibition [J]. Nature, 2006,439 ( 7074 ) : 358- 362.
  • 8Kwong LN, Costello JC, Liu H, et al. Oncogenic NRAS signaling dif- ferentially regulates survival and proliferation in melanoma [ J ]. Nat Med,2012,18(10) :1503-1510.
  • 9Grimaldi AM,Simeone E,Ascierto PA. The role of MEK inhibitors in the treatment of metastatic melanoma[ J]. Curr Opin Oncol,2014,26 (2) : 196-203.
  • 10Davies H,Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer[ J]. Nature ,2002,417 ( 6892 ) :949-954.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部